Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints Jeff Capello as executive VP and CFO

He will lead the company's business and finance planning functions

Jeff CapelloBiotechnology company Biogen has appointed Jeff Capello as its executive vice president and chief financial officer, roles which will see him lead the company’s business planning, tax, treasury, internal audit, accounting and investor relations functions.

Reporting to chief executive officer of Biogen, Michel Vounatsos, Capello will also become a member of the executive committee and he will be based in its Massachusetts office in the US.

He said: “I am very excited to join Biogen, a company which is recognised as a pioneer and a leader in treating neurological diseases and I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

Capello brings 26 years of experience in finance to Biogen, with his most recent role being executive vice president and chief financial officer at Beacon Health Options.

His career experience has seen him serve in various positions for Monomy Advisors, Ortho Clinical Diagnostics, Boston Scientific Corporation and Perkin Elmer.

Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.

“He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

5th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics